Document is current
Any future updates will be listed below
-
Authors
Messenger, Andrew G. https://orcid.org/0000-0003-1424-8069
Asfour, Leila https://orcid.org/0000-0002-0049-8377
Harries, Matthew https://orcid.org/0000-0002-0563-8690
- License Information
-
More Information
Article History
Accepted: 2 December 2024
First Online: 19 December 2024
Declarations
:
: No funding was received to assist with the preparation of this manuscript.
: AGM: Pfizer (consultant), Samson Clinical (shareholding). AGM is an Editorial Board member of the American Journal of Clinical Dermatology. AGM was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. LS: AbbVie (consultant, investigator), Sanofi (investigator), L’Oréal (consultant), Pfizer (education grant). MH: AbbVie (consultant, investigator), Eli Lilly (consultant), Pfizer (speaker, consultant), Sanofi (investigator).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The authors contributed equally to the design and production of the manuscript. The final version has been read and approved by all the authors.
